Treament of Rumination
NCT04167371 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2022-02-14
Summary
Background. Rumination syndrome is characterized by effortless recurrent regurgitation of recently ingested food into the mouth, with consequent expulsion or re-chewing and swallowing. In a previous study we showed that rumination is produced by an unperceived, somatic response to food ingestion. We developed an original biofeedback technique based on electromyography-guided control of abdominothoracic muscular activity. In a randomized, placebo-controlled trial we demonstrated the superiority of biofeedback over placebo for the treatment of rumination. However, the technique is technically complex and unpractical.
Aim. To prove the efficacy of a simplified biofeedback technique for the treatment of rumination. Selection criteria. Rumination after meal ingestion. Intervention. Patients will be randomized into biofeedback in placebo groups. Three sessions of either biofeedback or placebo intervention will be performed after ingestion of a probe meal during the first 3 weeks of the 4 weeks intervention period.
Biofeedback: patients will be taught to control abdominal and thoracic muscular activity by providing a visual display of the abdominal and thoracic perimeter; patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period.
Placebo: abdominal and thoracic perimeter will be recorded but not shown to the patient and a pill of placebo containing 0.5 g glucose will be administered; patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.
Primary Outcome Measure:
Number of rumination events measured by electromyography in response to the challenge meal before and after treatment.
Secondary Outcome Measures:
* Number of self perceived rumination events measured by questionnaires administered daily for 10 days will before and after treatment.
* Associated abdominal symptom measured by questionnaires administered daily for 10 days before and after treatment.
* Follow up: number of self perceived rumination events measured at 1, 3 and 6 months after treatment.
Conditions
- Rumination Disorders
Interventions
- BEHAVIORAL
-
Biofeedback
Three sessions by biofeedback will be performed during the first 3 weeks of the intervention period. In each session patients will be taught to control abdominal and thoracic muscular activity by providing a visual display of the abdominal and thoracic perimeter; patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period.
- DIETARY_SUPPLEMENT
-
Placebo
Three sessions will be performed during the first 3 weeks of the intervention period. In each session abdominal and thoracic perimeter will be recorded but not shown to the patient; patients will take a pill of placebo containing 0.5 g glucose and no specific instructions will be provided. Patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.
Sponsors & Collaborators
-
Hospital Universitari Vall d'Hebron Research Institute
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-02
- Primary Completion
- 2020-10-30
- Completion
- 2022-02-01
Countries
- Spain
Study Locations
More Related Trials
-
The Antigagging Effect of Granisetron (Kytril), an Antiemetic Drug, in Dental Situations
NCT00502437 ·Status: UNKNOWN ·Phase: NA
-
Quinine and Food Intake
NCT03565133 ·Status: COMPLETED ·Phase: NA
-
Effect of Oral Menthol on the Swallow Response of Patients With Oropharyngeal Dysphagia Associated With Neurological Diseases and Aging
NCT03050957 ·Status: COMPLETED ·Phase: PHASE2
-
Prokinetic Drugs and Enteral Nutrition
NCT00916591 ·Status: UNKNOWN
-
Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers
NCT02177890 ·Status: COMPLETED ·Phase: NA
-
Autonomic Reactivity and Personalized Neurostimulation
NCT06863207 ·Status: RECRUITING ·Phase: NA
-
Effect of Ginger on Nausea and Vomiting During Acute Gastroenteritis in Children
NCT02701491 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of 10mg Domperidone on Gastric Emptying of a High-fat Meal and Appetite Sensations in Healthy Adults
NCT01347814 ·Status: COMPLETED ·Phase: NA
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects
NCT00332137 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis
NCT02357420 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Vibrant Capsule on Gastric Emptying and Antropyloroduodenal Motility in Healthy Volunteers
NCT02736799 ·Status: COMPLETED ·Phase: NA
-
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
NCT06297954 ·Status: COMPLETED ·Phase: PHASE3
-
Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response
NCT03675321 ·Status: COMPLETED ·Phase: NA
-
Galvanic Vestibular Stimulation as a Novel Treatment for Seasickness
NCT05004818 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Itopride Versus Metoclopramide in Hospitalized Medicine Patients With High Gastric Residual Volume
NCT07031479 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Synergistic Gut-brain Axis Modulation Via Vagal Stimulation and Support Therapy in Functional Dyspepsia
NCT06360900 ·Status: RECRUITING ·Phase: NA
-
The Effect of Oxytocin on Gastric Emptying
NCT01152047 ·Status: COMPLETED ·Phase: NA
-
Open Label Transdermal Granisetron to Relieve Chronic Nausea and Emesis
NCT04501211 ·Status: WITHDRAWN ·Phase: PHASE2
-
Auriculotherapy and Acupuncture's Treatment for Chemotherapy-induced Nausea and Vomiting (CINV)
NCT02767791 ·Status: COMPLETED ·Phase: NA
-
Metoclopramide on Gastric Emptying in Mechanically Ventilated Patients
NCT05641051 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children
NCT03295760 ·Status: COMPLETED
-
Effectiveness of Acupuncture and Doxylamine/Pyridoxine for Moderate to Severe Nausea and Vomiting in Pregnancy
NCT04401384 ·Status: COMPLETED ·Phase: PHASE3
-
Medico-economic Evaluation of ENTERRA Therapy
NCT00903799 ·Status: COMPLETED ·Phase: NA
-
Domperidone in Treating Patients With Gastrointestinal Disorders
NCT01696734 ·Status: RECRUITING ·Phase: PHASE3